A Behavioral Activation Intervention Administered in a College Freshman Orientation Course
Launched by UNIVERSITY OF KANSAS · Jul 26, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help college freshmen address alcohol use and related challenges like stress, binge eating, and depression. Many students experience increased drinking during their transition to college, but not many seek help. The study will test a program that fits into a freshman seminar course, aiming to make it easier for students to engage in support without directly focusing on alcohol treatment. Instead, it will address the issues that are most relevant to new students, making it more approachable.
To participate, you need to be a college freshman enrolled in a specific seminar course at the University of Kansas. There are no specific exclusions, so if you're eligible, you can expect to take part in activities designed to help you manage these challenges in a supportive environment. This trial is currently recruiting participants, and it offers a unique opportunity to receive help during this important time in your life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • College freshmen enrolled in UNIV 101 freshman seminar courses at the University of Kansas assigned to the study
- Exclusion Criteria:
- • None
About University Of Kansas
The University of Kansas is a prestigious research institution committed to advancing knowledge and improving health outcomes through innovative clinical trials. As a sponsor, the university leverages its extensive academic resources and expertise to conduct rigorous research across various medical disciplines. With a focus on collaboration and scientific integrity, the University of Kansas aims to translate research findings into effective treatments and interventions, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lawrence, Kansas, United States
Patients applied
Trial Officials
Tera L Fazzino, PhD
Principal Investigator
University of Kansas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials